Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Lamy

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2023
Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder CancerEmil Christensen, Iver Nordentoft, Karin Birkenkamp-Demtröder, et al.
European Urology|September 17, 2023
Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder CancerTrine Strandgaard, Iver Nordentoft, Karin Birkenkamp-Demtröder, et al.
Cancer Research|August 5, 2016
Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial CarcinomaPhilippe Lamy, Iver Nordentoft, Karin Birkenkamp-Demtröder, et al.
International Journal of Cancer|November 2, 2012
Non-CpG island promoter hypomethylation and miR-149 regulate the expression of SRPX2 in colorectal cancerBodil Øster, Lene Linnet, Lise Lotte Christensen, et al.
Nature Communications|September 26, 2020
Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysisAnn Taber, Emil Christensen, Philippe Lamy, et al.
Nature Communications|April 5, 2022
Author Correction: Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysisAnn Taber, Emil Christensen, Philippe Lamy, et al.
Research Square|May 4, 2026
A unique transcriptomic landscape defines African-specific grade group 1 prostate cancerEva Ferlev Jensby, Korawich Uthayopas, Md Mehedi Hasan, et al.
Communications Biology|March 23, 2021
Targeting natural splicing plasticity of APOBEC3B restricts its expression and mutagenic activityA Rouf Banday, Olusegun O Onabajo, Seraph Han-Yin Lin, et al.
Cancer Research|June 3, 2009
Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitroLars Dyrskjøt, Marie S Ostenfeld, Jesper B Bramsen, et al.
Nature|October 18, 2005
A large dust/ice ratio in the nucleus of comet 9P/Tempel 1Michael Küppers, Ivano Bertini, Sonia Fornasier, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2023
Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder CancerEmil Christensen, Iver Nordentoft, Karin Birkenkamp-Demtröder, et al.
European Urology|September 17, 2023
Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder CancerTrine Strandgaard, Iver Nordentoft, Karin Birkenkamp-Demtröder, et al.
Cancer Research|August 5, 2016
Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial CarcinomaPhilippe Lamy, Iver Nordentoft, Karin Birkenkamp-Demtröder, et al.
International Journal of Cancer|November 2, 2012
Non-CpG island promoter hypomethylation and miR-149 regulate the expression of SRPX2 in colorectal cancerBodil Øster, Lene Linnet, Lise Lotte Christensen, et al.
Nature Communications|September 26, 2020
Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysisAnn Taber, Emil Christensen, Philippe Lamy, et al.
Nature Communications|April 5, 2022
Author Correction: Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysisAnn Taber, Emil Christensen, Philippe Lamy, et al.
Research Square|May 4, 2026
A unique transcriptomic landscape defines African-specific grade group 1 prostate cancerEva Ferlev Jensby, Korawich Uthayopas, Md Mehedi Hasan, et al.
Communications Biology|March 23, 2021
Targeting natural splicing plasticity of APOBEC3B restricts its expression and mutagenic activityA Rouf Banday, Olusegun O Onabajo, Seraph Han-Yin Lin, et al.
Cancer Research|June 3, 2009
Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitroLars Dyrskjøt, Marie S Ostenfeld, Jesper B Bramsen, et al.
Nature|October 18, 2005
A large dust/ice ratio in the nucleus of comet 9P/Tempel 1Michael Küppers, Ivano Bertini, Sonia Fornasier, et al.
Pageof 7